Skip to main content
Log in

Oxytocin does not modify the prolactin response to metoclopramide in normal women

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The present study was undertaken in order to establish whether oxytocin (OT) affects the dopaminergic control of PRL secretion in normal women during follicular, periovulatory and luteal phase of their menstrual cycle. For this purpose, 22 normal women were tested with a lower (1 mg) or higher (10 mg) dose of the dopaminergic antagonist metoclopramide (MCP) with or without the concurrent treatment with OT (2 IU injected plus 0.033 IU/min infused for 2 h). Since OT was found unable to modify the effect of either 1 or 10 mg MCP, in additional experiments the same doses of MCP and OT were administered after dopamine (0.04 µg/kg/min for 2 h) infusion. Also in these experimental conditions OT failed to modify the PRL response to MCP. These data argue against a role of OT in modulation of the dopaminergic control of PRL secretion in normal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baylis P.H. Posterior pituitary in health and disease. Clin. Endocrinol. Metab. 12: 747, 1983.

    Article  PubMed  CAS  Google Scholar 

  2. Vandesand F., Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat. Cell. Tissue Res. 164: 153, 1975.

    Google Scholar 

  3. Horn A.M., Robinson A.F., Fink G. Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal Brattleboro rats. J. Endocrinol. 104: 211, 1985.

    Article  PubMed  CAS  Google Scholar 

  4. Gibbs D.M. High concentrations of oxytocin in hypophysial portal plasma. Endocrinology 114: 1216, 1984.

    Article  PubMed  CAS  Google Scholar 

  5. Page S.R., Ang V.T.Y., Jackson R., White A., Nussey S.S., Jenkins J.S. The effect of oxytocin infusion on adenohypophyseal function in man. Clin. Endocrinol (Oxf.) 32: 307, 1990.

    Article  CAS  Google Scholar 

  6. Nussey S.S., Page S.R., Ang V.T.Y., Jenskins J.S. The effect of oxytocin infusion on adenohypophyseal and adrenal cortical responses to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.) 29: 257, 1988.

    Article  CAS  Google Scholar 

  7. Coiro V., Passeri M., Davoli C., Bacchi-Modena A., Bianconi L., Volpi R., Chiodera P. Oxytocin reduces-induced ACTH and cortisol rise in man. Acta Endocrinol. (Copenh.) 119: 405, 1988.

    CAS  Google Scholar 

  8. Lumpkin M.D., Samson W.K., McCann S.M. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Endocrinology 112: 1711, 1983.

    Article  PubMed  CAS  Google Scholar 

  9. Samson W.K., Lumpkin M.D., McCann S.M. Evidence for a physiological role for oxytocin in the control of prolactin secretion. Endocrinology 119: 554, 1986.

    Article  PubMed  CAS  Google Scholar 

  10. Johnston C.A., Negro Vilar A. Role of oxytocin on prolactin secretion during proestrous in different physiological or pharmacological paradigms. Endocrinology 122: 341, 1986.

    Article  Google Scholar 

  11. Coiro V., Gnudi A., Volpi R., Marchesi C., Salati G., Caffarra P., Chiodera P. Oxytocin enhances thyrotropin releasing hormone induced prolactin release in normal menstruating women. Fertil. Steril. 47: 565, 1987.

    PubMed  CAS  Google Scholar 

  12. Delitala G., Masala A., Alagna S., Devilla L. Effect of metoclopramide on serum prolactin levels in human. Clin. Endocrinol. (Oxf.) 5: 731, 1976.

    Article  CAS  Google Scholar 

  13. McCallum R.W., Sower J.R., Hershman J.M., Sturdevant R.A.L. Metoclopramide stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab. 42: 1148, 1976.

    Article  PubMed  CAS  Google Scholar 

  14. Kitaoka M., Takebe K., Kobayashi M., Nakazono M., Kudo M. Dose-dependency and reproducibility of prolactin response to metoclopramide. Horm. Metab. Res. 12: 155, 1980.

    Article  PubMed  CAS  Google Scholar 

  15. Agner T., Hagen C., Andersen A.N., Djursing H. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion. J. Clin. Endocrinol. Metab. 62: 778, 1986.

    Article  PubMed  CAS  Google Scholar 

  16. Sinha Y.N., Selby F.W., Lewis U.J., van der Laan W.P. A homologous radioimmunoassay for human prolactin. J. Clin. Endocrinol. Metab. 36: 509, 1973.

    Article  PubMed  CAS  Google Scholar 

  17. de Hertog R., Thomas K., Bietlot Y., Vanderheyden I., Ferin J. Plasma levels of unconjugated estrone, estradiol and estriol and HCS throughout pregnancy in normal women. J. Clin. Endocrinol. Metab. 40: 93, 1975.

    Article  Google Scholar 

  18. de Villa O., Roberts K., Wiest W.G., Mikhail G., Flickinger G. A specific radioimmunoassay of plasma progesterone. J. Clin. Endocrinol. Metab. 35: 458, 1972.

    Article  Google Scholar 

  19. Tashjian Jr A.H., Barowsky N.J., Jensen D.K. Thyrotropin-releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem. Biophys. Res. Commun. 43: 516, 1971.

    Article  PubMed  CAS  Google Scholar 

  20. Gershengorn M.C. Mechanism of thyrotropin-releasing hormone stimulation of pituitary hormone secretion. Am. Rev. Physiol. 48: 515, 1986.

    Article  CAS  Google Scholar 

  21. de Greef W.J., Visser T.J. Evidence for the involvement of hypothalamic dopaminic and thyrotropin-releasing hormone in suckling-induced release of prolactin. J. Endocrinol. 91: 213, 1981.

    Article  PubMed  Google Scholar 

  22. Mena F., Clapp C., Aguayo D., Martinez-Escalera G. Differential effects of thyrotropin-releasing hormone on in vitro release of in vivo or in vitro newley synthesized and mature prolactin by lactating rat adenohypophyses: further evidence for a sequential pattern of hormone release. Neuroendocrinology 49: 207, 1989.

    Article  PubMed  CAS  Google Scholar 

  23. Mena F., Clapp C., Aguayo D., Morales M.T., Grosvenor C.E., Martinez de la Escalera G. Regulation of prolactin secretion by dopamine and thyrotropin-releasing hormone in lactating rat adenohypophyses: influence of intracellular age of the hormone. Endocrinology 125: 1814, 1989.

    Article  PubMed  CAS  Google Scholar 

  24. MacLeod R.M., Lehmeyer J.E. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94: 1077, 1974.

    Article  PubMed  CAS  Google Scholar 

  25. Cheung C.Y., Kuhn R.W., Weiner R.I. Increased responsiveness of the dopamine-mediated inhibition of prolactin synthesis after destruction of the medial basal hypothalamus. Endocrinology 108: 747, 1981.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiodera, P., Volpi, R., Gramellini, D. et al. Oxytocin does not modify the prolactin response to metoclopramide in normal women. J Endocrinol Invest 14, 463–468 (1991). https://doi.org/10.1007/BF03346844

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346844

Key-words

Navigation